Analystreport

Innovate Biopharmaceuticals Inc (NASDAQ: INNT) had its "buy" rating re-affirmed by analysts at Seaport Global Securities.

INNOVATE BIOPHARMACEUTICALS  (INNT) 
Last innovate biopharmaceuticals earnings: 8/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.innovatebiopharma.com/news-releases